Torrent Pharmaceuticals LtdQ1 FY22
Torrent Pharmaceuticals Ltd Q1 FY22 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹4,763P/E: 64.7Market Cap: ₹1.5L CrSector: Pharmaceuticals & Biotechnology
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
No
0 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3No information is provided regarding the same in the latest conference call.
Margin guidance
Category 3No information is provided regarding the same in the latest conference call.
3 more insights locked — sign up free to unlock
Fundraise plans
No information is provided regarding the same in the latest conference call.
Order book
No information is provided regarding the same in the latest conference call.
Capex plans
NoNo information is provided regarding the same in the latest conference call.
How does Torrent Pharmaceuticals Ltd rank vs peers in Pharmaceuticals & Biotechnology?
Pro feature1Torrent Pharmaceuticals Ltd
Rev 3Mar 3
See full Pharmaceuticals & Biotechnology sector rankings